Interleukin 15 levels in serum may predict a severe disease course in patients with early arthritis
about
Anti-citrullinated protein antibodies are associated with decreased bone mineral density: baseline data from a register of early arthritis patients.Biomarkers predicting a need for intensive treatment in patients with early arthritisSystemic delivery of small interfering RNA targeting the interleukin-2/15 receptor β chain prevents disease progression in experimental arthritisCut-Offs and Response Criteria for the Hospital Universitario La Princesa Index (HUPI) and Their Comparison to Widely-Used Indices of Disease Activity in Rheumatoid ArthritisSynovial cytokine expression in psoriatic arthritis and associations with lymphoid neogenesis and clinical featuresPTGER4 gene variant rs76523431 is a candidate risk factor for radiological joint damage in rheumatoid arthritis patients: a genetic study of six cohorts.Modeling the pharmacokinetic-pharmacodynamic relationship of the monoclonal anti-macaque-IL-15 antibody Hu714MuXHu in cynomolgus monkeys.Novel approaches for treating musculoskeletal diseases: molecular orthopedics and systems medicine.Serum levels of vasoactive intestinal peptide as a prognostic marker in early arthritis.Differences in synovial fluid cytokine levels but not in synovial tissue cell infiltrate between anti-citrullinated peptide/protein antibody-positive and -negative rheumatoid arthritis patients.Targeting the synovial angiogenesis as a novel treatment approach to osteoarthritis.Interleukin-15-activated natural killer cells kill autologous osteoclasts via LFA-1, DNAM-1 and TRAIL, and inhibit osteoclast-mediated bone erosion in vitro.Development and validation of a multivariate predictive model for rheumatoid arthritis mortality using a machine learning approachValue of Measuring Anti-Carbamylated Protein Antibodies for Classification on Early Arthritis Patients.Comparative analysis of EV isolation procedures for miRNAs detection in serum samples.Vasoactive intestinal peptide gene polymorphisms, associated with its serum levels, predict treatment requirements in early rheumatoid arthritis.Methotrexate limits inflammation through an A20-dependent cross-tolerance mechanism.Enhanced and persistent levels of interleukin (IL)-17⁺ CD4⁺ T cells and serum IL-17 in patients with early inflammatory arthritis.Rituximab-induced interleukin-15 reduction associated with clinical improvement in rheumatoid arthritis.Autoantibodies to posttranslationally modified type II collagen as potential biomarkers for rheumatoid arthritis.Monocyte-related biomarkers of rheumatoid arthritis development in undifferentiated arthritis patients - a pilot study.Association of high titers of anti-carbamylated protein antibodies with decreased bone mineral density in early arthritis patients
P2860
Q31167745-B52F8AB4-4807-4192-B6B7-5DD70D2A0928Q34982012-3B0053E2-8DE5-448C-8C30-95AAD7A90AF6Q35040995-57977C4C-9617-41BB-93EA-FBB0BE24CCABQ36125286-E5700803-F470-45CF-9D33-2FC4FF2E7D65Q36245883-0A09F2E0-2C75-4A02-AA85-DC946A6FA5C9Q36251297-C7C1656F-A606-400B-8669-61673903CA03Q36648845-5C107AE7-80B9-4DEE-B59E-CBC0576D5792Q36876937-C41DD16A-D556-41A2-8C7F-449A36524159Q37445090-CB5FCE32-EC48-4C50-B8B8-40CD4EA0D954Q37690048-8F4B42E8-CA94-4E17-84C0-4B746CC31757Q38184546-3D701F09-A794-436B-9D0C-DC0C65E3E511Q41482320-012F2E4B-9888-4F40-88C8-38589F5E8705Q41581523-6F22FA6D-2DCB-4B8C-98B8-5363E5627252Q41697121-C6EB64CF-99B2-4A70-A189-2B7220310B1CQ41966705-617462A4-ABE1-49E5-A093-52059BB0A74EQ48120810-73029820-7D3D-4B2B-BD57-12BD30A3E156Q50047899-C6AD7009-ABA0-4E2B-9F2D-DD0B5E76B32DQ50866589-1BB7EB4D-2914-4A18-BFF4-26F4110F8BF8Q50872769-DB67DDA6-7601-44FA-9232-D506BFDCAAB2Q51075481-0BC27712-3CD7-49BD-B3B9-F1923993C7A6Q52568468-FBC203FC-6A3A-4FB7-86A1-DFF30E5E9CD8Q58771663-F42D012D-986A-4C89-8FAA-E82F97DA1FB9
P2860
Interleukin 15 levels in serum may predict a severe disease course in patients with early arthritis
description
2011 nî lūn-bûn
@nan
2011 թուականին հրատարակուած գիտական յօդուած
@hyw
2011 թվականին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Interleukin 15 levels in serum ...... patients with early arthritis
@ast
Interleukin 15 levels in serum ...... patients with early arthritis
@en
Interleukin 15 levels in serum ...... patients with early arthritis
@nl
type
label
Interleukin 15 levels in serum ...... patients with early arthritis
@ast
Interleukin 15 levels in serum ...... patients with early arthritis
@en
Interleukin 15 levels in serum ...... patients with early arthritis
@nl
prefLabel
Interleukin 15 levels in serum ...... patients with early arthritis
@ast
Interleukin 15 levels in serum ...... patients with early arthritis
@en
Interleukin 15 levels in serum ...... patients with early arthritis
@nl
P2093
P2860
P3181
P1433
P1476
Interleukin 15 levels in serum ...... patients with early arthritis
@en
P2093
Alicia Humbría
Ana M Ortiz
Belen Díaz-Sánchez
Esther F Vicente
Esther Patiño
Eva G Tomero
Inmaculada Carvajal
Isidoro González-Álvaro
J Pedro López-Bote
José María Alvaro-Gracia
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0029492
P407
P577
2011-12-29T00:00:00Z